The bonds of trust established between doctor and patient during an in-person clinical visit are important for ongoing care. What happens when the novel coronavirus makes that a risky encounter? Read Cleveland Clinic Cancer Center oncologist Mikkael Sekeres’ latest New York Times column.
A prototype blood-based screening test evaluated by Cleveland Clinic researchers and others can accurately detect and localize multiple types of cancer, often before symptoms show. The promising results raise hopes that the assay will help achieve the long-sought goal of population-scale early detection of cancer.
International patients and their physicians may need a translator to convey complex medical information and the questions that result. But sometimes, writes Cleveland Clinic Cancer Center oncologist Mikkael Sekeres, MD, words aren’t necessary.
A cancer diagnosis is life-changing, but it can be an especially disconcerting time for teenagers and young adults. Cleveland Clinic Cancer Center oncologist Mikkael Sekeres, MD, offers some insights into this special population in his latest New York Times column.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The investigational agent lustpatercept significantly lessens anemia severity and reduces or eliminates the need for transfusions in patients with low-risk myelodysplastic syndromes, a new phase 3 study involving Cleveland Clinic Cancer Center has found.
In his latest New York Times column, Cleveland Clinic hematologist/oncologist Mikkael Sekeres, MD, MS, reflects on the insights that come from photos of his patients in the electronic medical record.
Often, a cancer diagnosis imparts a sense of urgency — a desire on the part of the patient to begin treatment as soon as possible, to vanquish their disease and resume a normal life. But what does a physician do when a patient isn’t ready?
Cancer patients whose clinical trial participation helps drug makers commercialize new therapies shouldn’t have to pay for those lifesaving drugs, an oncologist argues.
On the cancer ward, patients’ addiction fears and their need for pain relief inevitably intersect. Oncologist Mikkael Sekeres, MD, MS, shares one experience.
An oncologist on why we should drop the penias and pathics in favor of plain language when we talk to patients.